Abstract
Multiple sclerosis (MS) is a chronic inflammatory demyelinating syndrome of the central nervous system (CNS). MS is a rare disease compared to the classic adult-onset MS. There have recently been improvements in the understanding of pediatric CNS demyelination, including pathogenesis, epidemiology, magnetic resonance imaging, laboratory features, and treatment. This chapter reviews the current understanding of these, including epidemiology and special health care needs in childhood MS.
Early assessment of factors that predict successful health outcomes and social inclusion of children with MS could guide supporting interventions such as social assistance, coaching, and psychological counseling, thus improving their community participation later on.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ADEM:
-
Acute disseminated encephalomyelitis
- CIS:
-
Clinically isolated syndrome
- CNS:
-
Central nervous system
- CSF:
-
Cerebrospinal fluid
- EBV:
-
Epstein Barr Virus
- EDSS:
-
Expanded disability status scale
- HB:
-
Hepatitis B
- HLA:
-
Human leukocyte antigen
- HRQ:
-
Health-related quality
- IFN:
-
Interferon
- IgG:
-
Immunoglobulin G
- MBP:
-
Myelin basic protein
- MOG:
-
Myelin oligodendrocyte glycoprotein
- MRI:
-
Magnetic resonance imaging
- MTR:
-
Magnetization transfer imaging
- MS:
-
Multiple sclerosis
- NMO:
-
Neuromyelitis optica
- OCB:
-
Oligoclonal bands
- RRMS:
-
Relapsing/remitting multiple sclerosis
- SD:
-
Standard deviation
References
Alotaibi, S., Kennedy, J., Tellier, R., Stephens, D., & Banwell, B. (2004) Epstein-Barr virus in pediatric multiple sclerosis. Journal of the American Medical Association, 29, 1875–1879.
Amato, M. P., Goretti, B., Ghezzi, A., Lori, S., Zipoli, V., Portaccio, E., Moiola, L., Falautano, M., De Caro, M. F., Lopez, M., Patti, F., Vecchio, R., Pozzilli, C., Bianchi, V., Roscio, M., Comi, G., Trojano, M., & Multiple Sclerosis Study Group of the Italian Neurological Society. (2008). Cognitive and psychosocial features of childhood and juvenile MS. Neurology, 70, 1891–1897.
Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernan, M. A., Olek, M. J., Hankinson, S. E., & Hunter, D. J. (2001). Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study. Journal of the American Medical Association, 26, 3083–3088.
Bager, P., Nielsen, N. M., Bihrmann, K., Frisch, M., Hjalgrim, H., Wohlfart, J., Koch-Henriksen, N., Melbye, M., & Westergaard, T. (2004). Childhood infections and risk of multiple sclerosis. Brain, 127, 2491–2497.
Banwell, B. L., & Anderson, P. E. (2005). The cognitive burden of multiple sclerosis in children. Neurology, 64, 891–894.
Banwell, B., Reder, A. T., Krupp, L., Tenembaum, S., Eraksoy, M., Alexey, B., Pohl, D., Freedman, M., Schelensky, L., & Antonijevic, I. (2006). Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology, 66, 472–476.
Banwell, B., Ghezzi, A., Bar-Or, A., Mikaeloff, Y., & Tardieu, M. (2007a). Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurology, 6, 887–902.
Banwell, B., Krupp, L., Kennedy, J., Tellier, R., Tenembaum, S., Ness, J., Belman, A., Boiko, A., Bykova, O., Waubant, E., Mah, J. K., Stoian, C., Kremenchutzky, M., Bardini, M. R., Ruggieri, M., Rensei, M., Hahn, J., Weinstock-Guttman, B., Yeh, E. A., Farrell, K., Freedman, M., Iivanainen, M., Sevon, M., Bhan, V., Dilenge, M. E., Stephens, D., & Bar-Or, A. (2007b). Clinical features and viral serologies in children with multiple sclerosis: A multinational observational study. Lancet Neurology, 6, 773–781.
Banwell, B., Tenembaum, S., Lennon, V. A., Ursell, E., Kennedy, J., Bar-Or, A., Weinshenker, B. G., Lucchinetti, C. F., & Pittock, S. J. (2008). Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology, 70, 344–352.
Banwell, B., Kennedy, J., Sadovnick, D., Arnold, D. L., Magalhaes, S., Wambera, K., Connolly, M. B., Yager, J., Mah, J. K., Shah, N., Sebire, G., Meaney, B., Dilenge, M. E., Lortie, A., Whiting, S., Doja, A., Levin, S., MacDonald, E. A., Meek, D., Wood, E., Lowry, N., Buckley, D., Yim, C., Awuku, M., Guimond, C., Cooper, P., Grand’Maison, F., Baird, J. B., Bhan, V., & Bar-Or, A. (2009). Incidence of acquired demyelination of the CNS in Canadian children. Neurology, 72, 232–239.
Blomquist, K. B. (2006). Health, education, work, and independence of young adults with disabilities. Orthopaedic Nursing, 25, 168–187.
Boiko, A., Vorobeychik, G., Paty, D., Devonshire, V., Sadovnick, D., & University of British Columbia MS Clinic Neurologists (2002a). Early onset multiple sclerosis: A longitudinal study. Neurology, 59, 1006–1010.
Boiko, A. N., Gusev, E. I., Sudomoina, M. A., Alekseenkov, A. D., Kulakova, O. G., Bikova, O. V., Maslova, O. I., Guseva, M. R., Boiko, S. Y., Guseva, M. E., & Favorova, O. O. (2002b). Association and linkage of juvenile MS with HLA-DR2(15) in Russians. Neurology, 58, 658–660.
Byrd, R. S., & Weitzman, M. L. (1994). Predictors of early grade retention among children in the United States. Pediatrics, 93, 481–487.
Callen, D. J., Shroff, M. M., Branson, H. M., Lotze, T., Li, D. K., Stephens, D., & Banwell, B. L. (2009) MRI in the diagnosis of pediatric multiple sclerosis. Neurology, 72, 961–967.
Chabas, D., Ness, J., Belman, A., Yeh, E. A., Kuntz, N., Gorman, M. P., Strober, J. B., De Kouchkovsky, I., McCulloch, C., Chitnis, T., Rodriguez, M., Weinstock-Guttman, B., Krupp, L. B., Waubant, E., & U.S. Network of Pediatric MS Centers of Excellence. (2010). Younger children with MS have a distinct CSF inflammatory profile at disease onset. Neurology, 74, 399–405.
Clerico, M., Barbero, P., Contessa, G., Ferrero, C., & Durelli, L. (2007). Adherence to interferon-beta treatment and results of therapy switching. Journal of the Neurological Sciences, 259, 104–108.
Cohen, B. A., & Rieckmann, P. (2007). Emerging oral therapies for multiple sclerosis. International Journal of Clinical Practice, 61, 1922–1930.
Collet, D. (1997). Time-dependent variables. In D. Collet (Ed.), Modelling survival data in medical research. London: Chapman and Hall.
Confavreux, C., Hutchinson, M., Hours, M. M., Cortinovis-Tourniaire, P., Moreau, T., & Pregnancy in Multiple Sclerosis Group. (1998). Rate of pregnancy-related relapse in multiple sclerosis. The New England Journal of Medicine, 339, 285–291.
Costello, I., Wong, I. C., & Nunn, A. J. (2004). A literature review to identify interventions to improve the use of medicines in children. Child Care Health and Development, 30, 647–665.
Cox, D. R. (1972) Regression models and life tables (with discussion). Journal of the Royal Statistical Society: Series B, 34, 187–202.
Dale, R. C., de Sousa, C., Chong, W. K., Cox, T. C., Harding, B., & Neville, B. G. (2000). Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain, 123, 2407–2422.
Dean, G., & Elian, M. (1997). Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 63, 565–568.
Dyment, D. A., Ebers, G. C., & Sadovnick, A. D. (2004). Genetics of multiple sclerosis. Lancet Neurology, 3, 104–110.
Ghezzi, A., Amato, M. P., Capobianco, M., Gallo, P., Marrosu, G., Martinelli, V., Milani, N., Milanese, C., Moiola, L., Patti, F., Pilato, V., Pozzilli, C., Trojano, M., Zaffaroni, M., & Comi, G. (2005a). Disease-modifying drugs in childhood-juvenile multiple sclerosis: Results of an Italian co-operative study. Multiple Sclerosis, 11, 420–424.
Ghezzi, A., & ITEMS (Immunomodulatory Treatment of Early Onset MS) Group. (2005b). Immunomodulatory treatment of early onset multiple sclerosis: Results of an Italian Co-operative Study. Neurological Sciences, 26, 183–186.
Ghezzi, A., Amato, M. P., Annovazzi, P., Capobianco, M., Gallo, P., La Mantia, L., Marrosu, M. G., Martinelli, V., Milani, N., Moiola, L., Patti, F., Pozzilli, C., Trojano, M., Zaffaroni, M., Comi, G., & ITEMS (Immunomodulatory Treatment of Early-onset MS) Group. (2009). Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: The Italian experience. Neurological Sciences, 30, 193–199.
Hahn, C. D., Shroff, M. M., Blaser, S. I., & Banwell, B. L. (2004). MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology, 62, 806–808.
Hernán, M. A., Olek, M. J., & Ascherio, A. (2001). Cigarette smoking and incidence of multiple sclerosis. American Journal of Epidemiology, 154, 69–74.
Hernán, M. A., Jick, S. S., Olek, M. J., & Jick, H. (2004). Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology, 63, 838–842.
Huppke, P., Stark, W., Zürcher, C., Huppke, B., Brück, W., & Gärtner, J. (2008). Natalizumab use in pediatric multiple sclerosis. Archives of Neurology, 65, 1655–1658.
Hynson, J. L., Kornberg, A. J., Coleman, L. T., Shield, L., Harvey, A. S., and Kean, M. J. (2001). Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology, 56, 1308–1312.
Julian, L. J., Vella, L., Vollmer, T., Hadjimichael, O., & Mohr, D. C. (2008). Employment in multiple sclerosis. Exiting and re-entering the work force. Journal of Neurology, 255, 1354–1360.
Kappos, L., Traboulsee, A., Constantinescu, C., Eralinna, J.-P., Forrestal, F., Jongen, P., Pollard, J., Sandberg-Wollheim, M., Sindic, C., Stubinski, B., Uitdehaag, B., & Li, D. (2006). Long-term subcutaneous interferon beta-1a therapy in patients with relapsing-remitting MS. Neurology, 67, 944–953.
Ketelslegers, I. A., Catsman-Berrevoets, C. E., Boon, M., Eikelenboom, M. J., Stroink, H., Neuteboom, R. F., Aarsen, F. K., van de Putte, E. M., & Hintzen, R. Q. (2010a). Fatigue and depression in children with multiple sclerosis and monophasic variants. European Journal of Paediatric Neurology, 14, 320–325.
Ketelslegers, I. A., Neuteboom, R. F., Boon, M., Catsman-Berrevoets, C. E., Hintzen, R. Q., & Dutch Pediatric MS Study Group. (2010b). A comparison of MRI criteria for diagnosing pediatric ADEM and MS. Neurology, 74, 1412–1415.
Kornek, B., Bernert, G., Balassy, C., Geldner, J., Prayer, D., & Feucht, M. (2003). Glatiramer acetate treatment in patients with childhood and juvenile onset multiple sclerosis. Neuropediatrics, 34, 120–126.
Kriss, A., Francis, D. A., Cuendet, F., Halliday, A. M., Taylor, D. S., Wilson, J., Keast-Butler, J., Batchelor, J. R., & McDonald, W. I. (1988). Recovery after optic neuritis in childhood. Journal of Neurology, Neurosurgery and Psychiatry, 51, 1253–1258.
Krupp, L. B., Banwell, B., Tenembaum, S., & International Pediatric MS Study Group. (2007). Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology, 68, S7–S12.
Kyngäs, H., Duffy, M. E., & Kroll, T. (2000). Conceptual analysis of compliance. Journal of Clinical Nursing, 9, 5–12.
Larocca, N., Kalb, R., Scheinberg, L., & Kendall, P. (1985). Factors associated with unemployment of patients with multiple sclerosis. Journal of Chronic Diseases, 38, 203–210.
Lennon, V. A., Kryzer, T. J., Pittock, S. J., Verkman, A. S., & Hinson, S. R. (2005). IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. The Journal of Experimental Medicine, 202, 473–477.
Lucchinetti, C. F., Kiers, L., O’Duffy, A., Gomez, M. R., Cross, S., Leavitt, J. A., O’Brien, P., & Rodriguez, M. (1997). Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology, 49, 1413–1418.
MacAllister, W. S., Belman, A. L., Milazzo, M., Weisbrot, D. M., Christodoulou, C., Scherl, W. F., Preston, T. E., Cianciulli, C., & Krupp, L. B. (2005). Cognitive functioning in children and adolescents with multiple sclerosis. Neurology, 64, 1422–1425.
MacAllister, W. S., Christodoulou, C., Troxell, R., Milazzo, M., Block, P., Preston, T. E. , Bender, H. A., Belman, A., & Krupp, L. B. (2009). Fatigue and quality of life in pediatric multiple sclerosis. Multiple Sclerosis, 15, 1502–1508.
Makhani, N., Gorman, M. P., Branson, H. M., Stazzone, L., Banwell, B. L., & Chitnis, T. (2009). Cyclophosphamide therapy in pediatric multiple sclerosis. Neurology, 72, 2076–2082.
Marrie, R. A. (2004). Environmental risk factors in multiple sclerosis aetiology. Lancet Neurology, 3, 709–718.
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H.-P., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., Sandberg-Wollheim, M., Sibley, W., Thompson, A., Van Den Noort, S., Weinshenker, B. Y., & Wolinsky, J. S. (2001). Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology, 50, 121–127.
McKeon, A., Lennon, V. A., Lotze, T., Tenembaum, S., Ness, J. M., Rensel, M., Kuntz, N. L., Fryer, J. P., Homburger, H., Hunter, J., Weinshenker, B. G., Krecke, K., Lucchinetti, C. F., & Pittock, S. J. (2008). CNS aquaporin-4 autoimmunity in children. Neurology, 71, 93–100.
McLaughlin, K. A., Chitnis, T., Newcombe, J., Franz, B., Kennedy, J., McArdel, S., Kuhle, J., Kappos, L., Rostasy, K., Pohl, D., Gagne, D., Ness, J. M., Tenembaum, S., O’Connor, K. C., Viglietta, V., Wong, S. J., Tavakoli, N. P., de Seze, J., Idrissova, Z., Khoury, S. J., Bar-Or, A., Hafler, D. A., Banwell, B., & Wucherpfennig, K. W. (2009). Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis. Journal of Immunology, 183, 4067–4076.
Mikaeloff, Y., Moreau, T., Debouverie, M., Pelletier, J., Lebrun, C., Gout, O., Pedespan, J.-M., Van Hulle, C., Vermersch, P., & Ponsot, G. (2001). Interferon ß treatment in patients with childhood onset multiple sclerosis. Journal of Pediatric, 139, 443–446.
Mikaeloff, Y., Suissa, S., Vallee, L., Lubetzki, C., Ponsot, G., Confavreux, C., Tardieu, M., & KIDMUS Study Group. (2004a). First episode of acute inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. Journal of Pediatric, 144, 246–252.
Mikaeloff, Y., Adamsbaum, C., Husson, B., Vallee, L., Ponsot, G., Confavreux, C., Tardieu, M., Suissa, S., & KIDMUS Study Group on Radiology. (2004b). MRI prognostic factors for relapse after a first episode of acute CNS inflammatory demyelination in childhood. Brain, 127, 1942–1947.
Mikaeloff, Y., Caridade, G., Assi, S., Suissa, S., & Tardieu, M. (2006). Prognostic factors and early severity score in a cohort of childhood multiple sclerosis. Pediatrics, 118, 1133–1139.
Mikaeloff, Y., Caridade, G., Husson, B., Suissa, S., Tardieu, M., & Neuropediatric KIDSEP Study Group of the French Neuropediatric Society. (2007a). Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse. European Journal of Paediatric Neurology, 11, 90–95.
Mikaeloff, Y., Caridade, G., Assi, S., Tardieu, M., Suissa, S., & KIDSEP study group of the French Neuropaediatric Society. (2007b). Hepatitis B vaccine and risk of relapse after a first childhood episode of CNS inflammatory demyelination. Brain, 130, 1105–1110.
Mikaeloff, Y., Caridade, G., Rossier, M., Suissa, S., & Tardieu, M. (2007c). Hepatitis B vaccination and the risk of childhood-onset multiple sclerosis. Archives of Pediatrics & Adolescent Medicine, 161, 1176–1182.
Mikaeloff, Y., Caridade, G., Tardieu, M., Suissa, S., & KIDSEP study group. (2007d). Parental smoking at home and the risk of childhood-onset multiple sclerosis in children. Brain, 130, 2589–2595.
Mikaeloff, Y., Caridade, G., Rossier, M., Tardieu, M., Suissa, S., & KIDSEP Study Group of the French Neuropediatric Society. (2008). Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study. European Journal of Paediatric Neurology, 12, 205–209.
Mikaeloff, Y., Caridade, G., Suissa, S., Tardieu, M., & KIDSEP Study Group. (2009). Clinically observed chickenpox and the risk of childhood-onset multiple sclerosis. American Journal of Epidemiology, 169, 1260–1266.
Mikaeloff, Y., Caridade, G., Billard, C., Bouyer, J., & Tardieu, M. (2010a). School performance in a cohort of children with CNS inflammatory demyelination. European Journal of Paediatric Neurology, 14, 418–424.
Mikaeloff, Y., Dale, R. C., & Tardieu, M. (2010b). Childhood multiple sclerosis. In: R. C. Dale & A. Vincent (Eds.), Inflammatory and autoimmune disorders of the nervous system in children (pp. 48–64). London: Mac Keith Press.
Mowry, E. M., Krupp, L. B., Milazzo, M., Chabas, D., Strober, J. B., Belman, A. L., McDonald, J. C., Oksenberg, J. R., Bacchetti, P., & Waubant, E. (2010). Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Annals of Neurology, 67, 618–624.
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006). Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association, 296, 2832–2838.
Noronha, A. (2007). Neutralizing antibodies to interferon. Neurology, 68, 16–22.
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) Multiple sclerosis. The New England Journal of Medicine, 343, 938–952.
O’Connor, R. J., Cano, S. J., Ramio, I., Torrenta, L., Thompson, A. J., & Playford, E. D. (2005). Factors influencing work retention for people with multiple sclerosis: Cross-sectional studies using qualitative and quantitative methods. Journal of Neurology, 252, 892–896.
O’Connor, K. C., Lopez-Amaya, C., Gagne, D., Lovato, L., Moore-Odum, N. H., Kennedy, J., Krupp, L., Tenembaum, S., Ness, J., Belman, A., Boyko, A., Bykova, O., Mah, J. K., Stoian, C. A., Waubant, E., Kremenchutzky, M., Ruggieri, M., Bardini, M. R., Rensel, M., Hahn, J., Weinstock-Guttman, B., Yeh, E. A., Farrell, K., Freedman, M. S., Iivanainen, M., Bhan, V., Dilenge, M., Hancock, M. A., Gano, D., Fattahie, R., Kopel, L., Fournier, A. E., Moscarello, M., Banwell, B., & Bar-Or, A. (2010). Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis. Journal of Neuroimmunology, 223, 92–99.
Ohlenbusch, A., Pohl, D., & Hanefeld, F. (2002). Myelin oligodendrocyte gene polymorphisms and childhood multiple sclerosis. Pediatric Research, 52, 175–179.
Pagani, L., Tremblay, R. E., Vitaro, F., Boulerice, B., & McDuff, P. (2001). Effects of grade retention on academic performance and behavioral development. Development and Psychopathology, 13, 297–315.
Pfleger, C. C., Flachs, E. M., & Koch-Henriksen, N. (2010). Social consequences of multiple sclerosis (1): Early pension and temporary unemployment—a historical prospective cohort study. Multiple Sclerosis, 16, 121–126.
PISA: Programme for International Student Assessment. (2007). In: OECD’s (Ed.). http://www.oecd.org/document/31/0,3343,fr_2649_34487_39720927_1_1_1_1,00.html.
Pohl, D. (2008). Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions. Current Opinion in Neurology, 21, 366–372.
Pohl, D., Rostasy, K., Reiber, H., & Hanefeld, F. (2004). CSF characteristics in early-onset multiple sclerosis. Neurology, 63, 1966–1967.
Pohl, D., Rostasy, K., Gärtner, J., & Hanefeld, F. (2005). Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1-a. Neurology, 64, 888–890.
Pohl, D., Krone, B., Rostasy, K., Kahler, E., Brunner, E., Lehnert, M., Wagner, H. J., Gärtner, J., & Hanefeld, F. (2006). High seroprevalence of Epstein-Barr virus in children with multiple sclerosis. Neurology, 67, 2063–2065.
Polman, C. H., Reingold, S. C., Edan, G., Filippi, M., Hartung, H.-P., Kappos, L., Lublin, F. D., Metz, L. M., McFarland, H. F., O’Connor, P. W., Sandberg-Wollheim, M., Thompson, A. J., Weinshenker, B. G., & Wolinsky, J. S. (2005). Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria”. Annals of Neurology, 58, 840–846.
Pritchard, M. T., Butow, P. N., Stevens, M. M., & Duley, J. A. (2006). Understanding medication adherence in pediatric acute lymphoblastic leukemia: A review. Journal of Pediatric Hematology Oncology, 28, 816–823.
Rapoff, M. A. (2006). Management of adherence and chronic rheumatic disease in children and adolescents. Best Practice & Research: Clinical Rheumatology, 20, 301–314.
Renoux, C., Vukusic, S., Mikaeloff, Y., Edan, G., Clanet, M., Dubois, B., Debouverie, M., Brochet, B., Lebrun-Frenay, C., Pelletier, J., Moreau, T., Lubetzki, C., Vermersch, P., Roullet, E., Magy, L., Tardieu, M., Suissa, S., Confavreux, C. &, Adult Neurology Departments KIDMUS Study Group. (2007). Natural history of multiple sclerosis with childhood onset. The New England Journal of Medicine, 356, 2603–2613.
Riikonen, R., Ketonen, L., & Sipponen, J. (1988). Magnetic resonance imaging, evoked responses and cerebrospinal fluid findings in a follow-up study of children with optic neuritis. Acta Neurologica Scandinavica, 77, 44–49.
Riise, T., Norvtvedt, M. W., & Ascherio, A. (2003). Smoking is a risk factor for multiple sclerosis. Neurology, 61, 1122–1124.
Rostasy, K., Reiber, H., Pohl, D., Lange, P., Ohlenbusch, A., Eiffert, H., Maass, M., & Hanefeld, F. (2003). Chlamydia pneumoniae in children with MS: Frequency and quantity of intrathecal antibodies. Neurology, 61, 125–128.
Sabbagh, S. E., Soria, C., Escolano, S., Bulteau, C., & Dellatolas, G. (2006). Impact of epilepsy characteristics and behavioral problems on school placement in children. Epilepsy & Behavior, 9, 573–578.
Sadovnick, A. D., Armstrong, H., Rice, G. P., Bulman, D., Hashimoto, I., Paty, D. W., Hashimoto, S. A., Warren, S., Hader, W., Murray, T. J., Seland, T. P., Metz, L., Bell, R., Duquette, P., Gray, T., Nelson, R., Weinshenker, B., Brunet, D., & Ebers, G. C. (1993). A population-based study of multiple sclerosis in twins: Update. Annals of Neurology, 33, 281–285.
Salter, A. R., Cutter, G. R., Tyry, T., Marrie, R. A., & Vollmer, T. (2010). Impact of loss of mobility on instrumental activities of daily living and socioeconomic status in patients with MS. Current Medical Research and Opinion, 26, 493–500.
Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L., Trivedi, P., Salvetti, M., Faggioni, A., & Aloisi, F. (2007). Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. The Journal of Experimental Medicine, 204, 2899–2912.
Shaw, R. J., Palmer, L., Blasey, C., & Sarwal, M. (2003). A typology of non-adherence in pediatric renal transplant recipients. Pediatric Transplantation, 7, 489–493.
Simone, I. L., Carrara, D., Tortorella, C., Liguori, M., Lepore, V., Pellegrini, F., Bellacosa, A., Ceccarelli, A., Pavone, I., & Livrea, P. (2002). Course and prognosis in early-onset MS: Comparison with adult-onset forms. Neurology, 59, 1922–1928.
Strom, B. L. (2005). Pharmacoepidemiology (4th ed.). Chichester: Wiley.
Tenembaum, S. N., & Segura, M. J. (2006). Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology, 67, 511–513.
Tenembaum, S. N, Chamoles, N., & Fejerman, N. (2002). Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology, 59, 1224–1231.
Thannhauser, J. E., Mah, J. K., & Metz, L. M. (2009). Adherence of adolescents to multiple sclerosis disease-modifying therapy. Pediatric Neurology, 41, 119–123.
Treadaway, K., Cutter, G., Salter, A., Lynch, S., Simsarian, J., Corboy, J., Jeffery, D., Cohen, B., Mankowski, K., Guarnaccia, J., Schaeffer, L., Kanter, R., Brandes, D., Kaufman, C., Duncan, D., Marder, E., Allen, A., Harney, J., Cooper, J., Woo, D., Stuve, O., Racke, M., & Frohman, E. M. (2009). Factors that influence adherence with disease-modifying therapy in MS. Journal of Neurology, 256, 568–576.
Wilejto, M., Shroff, M., Buncic, J. R., Kennedy, J., Goia, C., & Banwell, B. (2006). The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology, 67, 258–262.
Yeh, E. A., Chitnis, T., Krupp, L., Ness, J., Chabas, D., Kuntz, N., Waubant, E., & U.S. Network of Pediatric Multiple Sclerosis Centers of Excellence. (2009). Pediatric multiple sclerosis. Nature Reviews Neurology, 5, 621–631.
Acknowledgments
I thank Velina Minkoff for helpful comments regarding the English language. Yann Mikaeloff is supported by Université Paris Sud 11, Institut National de la Recherche Médicale (INSERM) and Assistance publique-hôpitaux de Paris.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this chapter
Cite this chapter
Mikaeloff, Y. (2012). Children with Multiple Sclerosis. In: Hollar, D. (eds) Handbook of Children with Special Health Care Needs. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2335-5_11
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2335-5_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2334-8
Online ISBN: 978-1-4614-2335-5
eBook Packages: MedicineMedicine (R0)